Azlocillin

This classification denotes a penicillin antibiotic with the molecular formula C20H23N5O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HUM6H389W0, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as azlocillin, which bears US NIH Compound Identifier 37625. Azlocillin most often comes in base and sodium forms. European Medicines Agency schedules Azlocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05661MIG. The term AZLOCILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules azlocillin in its Anatomical Therapeutic Chemical (ATC) Classification. AZLOCILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azlocillin under HS 29411090 and SITC 54131. As of Q4 2014, AZLOCILLIN remains the US FDA Preferred Term for this commodity. Azlocillin bears US NLM identifiers UMLS ID C0004499 and NCI Concept Code C293. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(NC(=O)N1CCNC1=O)C1CCCCC1.